I Thought I Was Saving Trans Kids. Now I’m Blowing the Whistle.

GLP-1 Feud Ends: NOVO, HIMS Join Forces (Again) To Sell Obesity Drugs The epic, months-long GLP-1 feud between Novo Nordisk and telehealth firm Hims & Hers Health appears to be coming to a surprising end, with both companies reportedly set to announce, as soon as Monday, a new partnership that would allow the Danish drugmaker to sell Wegovy through HIMS' platform. Bloomberg published the report late Friday, stating: Novo Nordisk A/S plans to sell its weight-loss drugs on Hims & Hers Health Inc.'s platform, according to a person familiar with the matter... ... Novo...

ADP Employment Reports Shows Better Than Expected Job Gains, Accelerating Wages Hiring and pay gains both held steady in March. The ADP National Employment report printed a better than expected +62k jobs added in March (+40k exp) and modestly down from an upwardly revised 66k in February. That is the ninth straight month of job gains. Source: Bloomberg The smallest employers drove job growth for a second month, while hiring in trade, transportation, and utilities continued to decline. "Overall hiring is steady, but job growth continues to favor certain industries, including health care. In March,...

Iran’s PressTV reported on Wednesday that Tehran has rejected the Trump administration’s 15-point proposal to end the war the US and Israel launched on February 28 and laid out its own conditions to end the conflict. “Iran will end the war when it decides to do so and when its own conditions are met,” an […]